71.73
Precedente Chiudi:
$71.36
Aprire:
$71.08
Volume 24 ore:
780.50K
Relative Volume:
0.86
Capitalizzazione di mercato:
$12.41B
Reddito:
$8.31B
Utile/perdita netta:
$379.00M
Rapporto P/E:
33.21
EPS:
2.16
Flusso di cassa netto:
$385.00M
1 W Prestazione:
-4.04%
1M Prestazione:
-7.91%
6M Prestazione:
-3.15%
1 anno Prestazione:
+23.54%
Solventum Corp Stock (SOLV) Company Profile
Nome
Solventum Corp
Settore
Industria
Telefono
651-733-1110
Indirizzo
C/O 3M COMPANY, ST. PAUL
Confronta SOLV con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
SOLV
Solventum Corp
|
71.73 | 12.35B | 8.31B | 379.00M | 385.00M | 2.16 |
![]()
ISRG
Intuitive Surgical Inc
|
483.12 | 172.46B | 9.15B | 2.61B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
176.37 | 51.09B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
87.87 | 43.30B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
279.20 | 39.87B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
239.26 | 17.20B | 2.90B | 467.20M | 306.90M | 6.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-07-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2025-07-01 | Aggiornamento | Argus | Hold → Buy |
2025-06-06 | Iniziato | KeyBanc Capital Markets | Sector Weight |
2025-05-19 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2024-12-04 | Iniziato | Mizuho | Neutral |
2024-10-08 | Iniziato | Stifel | Buy |
2024-10-07 | Iniziato | Piper Sandler | Neutral |
2024-09-26 | Iniziato | Wolfe Research | Peer Perform |
2024-09-05 | Iniziato | BTIG Research | Neutral |
2024-06-24 | Iniziato | Argus | Hold |
2024-05-30 | Iniziato | Goldman | Sell |
2024-05-10 | Iniziato | BofA Securities | Neutral |
2024-04-10 | Iniziato | Morgan Stanley | Equal-Weight |
2024-04-08 | Iniziato | Wells Fargo | Equal Weight |
2024-04-02 | Iniziato | Edward Jones | Hold |
Mostra tutto
Solventum Corp Borsa (SOLV) Ultime notizie
How many analysts rate Solventum Corporation as a “Buy”Build wealth faster with consistent investment plans - jammulinksnews.com
How strong is Solventum Corporation company’s balance sheetCapitalize on market trends with expert guidance - jammulinksnews.com
What is the dividend policy of Solventum Corporation stockSkyrocketing profit margins - jammulinksnews.com
Morgan Stanley Upgrades Solventum (SOLV) on Growth Potential - MSN
What institutional investors are buying Solventum Corporation stockMarket Forecast Recommendation With Low Risk - jammulinksnews.com
11 Best Medical Stocks to Buy According to Analysts - Insider Monkey
Stock Analysis | Solventum OutlookTechnical Weakness and Analyst Disagreement Cloud Near-Term Prospects - AInvest
Sector Leaders Rotate Capital Into Solventum CorporationBreakout Confirmation With Entry Tracker Enabled - beatles.ru
Building trade automation scripts for Solventum CorporationReal Trader Watchlist of Hot Stocks Released - metal.it
Why Solventum Corporation stock attracts strong analyst attentionDaily Growth Stock Pick Reports Show Bullish Signals - metal.it
Advanced Wound Care Market to Hit $19.32 Billion by 2030 – What’s Fueling the Surge? | MarketsandMarkets™. - GlobeNewswire Inc.
What makes Solventum Corporation stock price move sharplyTarget Return Focused Trade Insights Shared - beatles.ru
What are the latest earnings results for Solventum CorporationOutstanding risk-reward balance - jammulinksnews.com
Is it the right time to buy Solventum Corporation stockBuild wealth with reliable stock picks - jammulinksnews.com
When is Solventum Corporation stock expected to show significant growthTrack high-yield stocks before they peak - jammulinksnews.com
Assessing the Strategic and Financial Implications of 3M's Spin-Off of Solventum - AInvest
3M Company: Adjusting to Solventum Spinoff and MMM Stock Performance - AInvest
3M Company: Still Adjusting To Spinoff Of Solventum (NYSE:MMM) - Seeking Alpha
What are Solventum Corporation company’s key revenue driversExceptional return forecasts - jammulinksnews.com
What to Expect From Solventum's Q2 2025 Earnings Report - MSN
Solventum Corporation Stock Analysis and ForecastConsistently high yield - PrintWeekIndia
Solventum Corporation's Anticipated Q2 2025 Earnings ReleaseNews and Statistics - IndexBox
What To Expect From Solventum's Q2 2025 Earnings Report - Barchart.com
Solventum to Report Second Quarter Fiscal 2025 Earnings on August 7, 2025 - StreetInsider
Lobbying Update: $60,000 of SOLVENTUM lobbying was just disclosed - Nasdaq
What analysts say about Solventum Corporation stockExtraordinary market timing - jammulinksnews.com
Solventum: Appealing Again (NYSE:SOLV) - Seeking Alpha
Is Solventum Corporation a good long term investmentExceptional growth trajectory - jammulinksnews.com
What drives Solventum Corporation stock priceOutstanding trading profits - jammulinksnews.com
Steris, Solventum upgraded, RxSight downgraded in Morgan Stanley's MedTech review - MSN
As more Minnesota companies rethink remote work, Solventum and others hold the line on flexibility - MSN
Earnings Alert: Solventum Sets Q2 2025 Report Date, Management to Discuss Future Outlook - Stock Titan
Solventum Corp Azioni (SOLV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):